Prieto L, Gutiérrez V, Morales C, Perpiñan J, Inchaurraga I
Sección de Alergia, Hospital Dr. Peset, Valencia, Spain.
Ann Allergy Asthma Immunol. 1998 Feb;80(2):151-8. doi: 10.1016/S1081-1206(10)62948-1.
Previous studies have demonstrated a significant correlation between airway sensitivity to pharmacologic agents and daily peak expiratory flow rate (PEF) variation in asthmatic and nonasthmatic subjects.
The aim of this study was to investigate, both in patients with asthma and in subjects with allergic rhinitis, differences in daily PEF variation between subjects with plateau on the concentration-response curves to methacholine and those without plateau.
A total of 120 adults (50 with mild asthma, 52 with allergic rhinitis, and 18 healthy control subjects) were challenged with methacholine (up to 200 mg/mL) and, for the next 14 days, measured their PEF three times daily. The response to methacholine was measured by the percent decrease in FEV1. A maximal response plateau was considered if three or more of the highest concentrations fell within a 5% response range. Diurnal PEF variation was expressed as the amplitude percent mean.
A plateau response was detected in 11 (22%) asthmatic patients, in 33 (63%) subjects with allergic rhinitis, and in 17 (94%) healthy subjects. Diurnal PEF variation was significantly greater (P < .01) in the asthmatic group without a plateau (8.8 +/- 3.7%) compared with the three groups with a plateau (asthma = 5.5 +/- 2.9%; allergic rhinitis = 4.6 +/- 2.1%; healthy = 4.7 +/- 2.3%). Those three groups with a plateau were not significantly different from each other with respect to PEF variability. Diurnal PEF variation was significantly higher in allergic rhinitis patients without plateau (7.6 +/- 3.5%) than in allergic rhinitis patients with plateau (P < .01) and healthy subjects (P < .05). The rhinitic group without a plateau, however, was not significantly different from either the asthmatic group without plateau or the asthmatic group with plateau.
We conclude that in both asthmatic patients and subjects with allergic rhinitis, the shape of the concentration-response curve to methacholine provides new information on the relationship between airway responsiveness and PEF variability. Further, allergic rhinitis subjects without evidence of plateau have a degree of diurnal PEF variation similar to that found in patients with mild asthma. This could indicate that those subjects may have subclinical inflammatory changes in the airways.
既往研究表明,在哮喘患者和非哮喘患者中,气道对药物的敏感性与每日呼气峰值流速(PEF)变化之间存在显著相关性。
本研究旨在调查哮喘患者和过敏性鼻炎患者中,对乙酰甲胆碱浓度-反应曲线有平台期的受试者与无平台期的受试者之间每日PEF变化的差异。
总共120名成年人(50名轻度哮喘患者、52名过敏性鼻炎患者和18名健康对照者)接受了乙酰甲胆碱(最高达200mg/mL)激发试验,并在接下来的14天里,每天测量3次他们的PEF。通过第1秒用力呼气容积(FEV1)下降百分比来测量对乙酰甲胆碱的反应。如果三个或更多最高浓度落在5%的反应范围内,则认为存在最大反应平台期。日间PEF变化以平均幅度百分比表示。
在11名(22%)哮喘患者、33名(63%)过敏性鼻炎患者和17名(94%)健康受试者中检测到平台期反应。与有平台期的三组(哮喘组 = 5.5±2.9%;过敏性鼻炎组 = 4.6±2.1%;健康组 = 4.7±2.3%)相比,无平台期的哮喘组日间PEF变化显著更大(P <.01)(8.8±3.7%)。有平台期的这三组在PEF变异性方面彼此无显著差异。无平台期的过敏性鼻炎患者的日间PEF变化(7.6±3.5%)显著高于有平台期的过敏性鼻炎患者(P <.01)和健康受试者(P <.05)。然而,无平台期的鼻炎组与无平台期的哮喘组或有平台期的哮喘组相比,无显著差异。
我们得出结论,在哮喘患者和过敏性鼻炎患者中,对乙酰甲胆碱的浓度-反应曲线形状为气道反应性与PEF变异性之间的关系提供了新的信息。此外,无平台期证据的过敏性鼻炎受试者的日间PEF变化程度与轻度哮喘患者相似。这可能表明这些受试者气道可能存在亚临床炎症变化。